186 results on '"Holy, Erik W."'
Search Results
2. Clinical outcomes of ultrasound-assisted coagulation monitoring-adjusted catheter-directed thrombolysis for acute pulmonary embolism
3. Outcomes of acute coronary syndromes in coronavirus disease 2019
4. Clinical outcomes of a balloon-expandable stent for symptomatic obstructions of the subclavian or innominate arteries
5. Contributors
6. Transcatheter closure of atrial septal defect and a patent foramen ovale in adults
7. A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance Imaging
8. Impact of stroke volume assessment by integrating multi-detector computed tomography and Doppler data on the classification of aortic stenosis
9. Percutaneous large-bore aspiration embolectomy with veno-arterial extracorporal membrane oxygenation support or standby in patients with high-risk pulmonary embolism and contraindications to thrombolysis: a preliminary single centre experience
10. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes
11. Prognostic value of aortic regurgitation after TAVI in patients with chronic kidney disease
12. Update zum Thema Lungenembolie: leitliniengerechte Diagnostik und Therapie anhand eines Fallbeispiels
13. Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter Study
14. Update zum Thema Lungenembolie: leitliniengerechte Diagnostik und Therapie anhand eines Fallbeispiels
15. Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients
16. Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathways
17. Carbamylated low-density lipoprotein induces endothelial dysfunction
18. Outcomes of acute coronary syndromes in coronavirus disease 2019
19. Perkutane koronare Revaskularisation beim chronischen Koronarsyndrom: wann sinnvoll, wann nicht?
20. Myocardial edema in COVID-19 on cardiac MRI
21. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design
22. Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis
23. Chapter 44 - Transcatheter closure of atrial septal defect and a patent foramen ovale in adults
24. A journey into the heart: moderne Behandlung der koronaren Herzerkrankung
25. ENDOTHELIAL OVEREXPRESSION OF LOX-1 DECREAES ARETERIAL THROMBOSIS AND TF EXPRESSION IN VIVO: ROLE OF SIRT-1 AND NFκB.: 1
26. Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients
27. Redox-sensitive impairment of porcine coronary artery vasodilation by hypochlorite-modified LDL
28. A young woman with recurrent spontaneous coronary artery dissection
29. Tissue Factor in Cardiovascular Disease
30. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells
31. Impact of a nationwide COVID-19 lockdown on acute coronary syndrome referrals
32. Multimodality imaging derived energy loss index and outcome after transcatheter aortic valve replacement
33. Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor
34. Prothrombotic Dysfunctional Lipoproteins: Triggers of Arterial Thrombus Formation Molecular Mechanisms and Clinical Implications
35. Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis
36. Moderne Therapie der stabilen koronaren Herzkrankheit: Der Stellenwert der koronaren Revaskularisation
37. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design
38. Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis
39. Procedural and Clinical Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
40. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman
41. Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis.
42. Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure
43. Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis
44. Long-Term Clinical Outcome of Early Generation Versus New-Generation Drug-Eluting Stents in 481 Patients Undergoing Rotational Atherectomy: A Retrospective Analysis
45. Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1: Impact on Arterial Thrombus Formation In Vivo
46. Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
47. Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium
48. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman
49. Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis
50. Redo TAVI: initial experience at two German centres
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.